Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/5/12 → 10/5/15 |
Funding
- PRA Health Sciences (Prot # GS-US-337-0102 // Prot # GS-US-337-0102)
- Gilead Sciences, Inc (Prot # GS-US-337-0102 // Prot # GS-US-337-0102)
Prot # GS-US-337-0102: A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885 Fixed Dose Combination ± Ribavarin for 12 and 24 Weeks in Treatment-Naive Subjects with Chronic Genotype 1 HCV Infecti
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-PD/PI)
Project: Research project